- Home
- LENZ vs AMRN Comparison
LENZ vs AMRN Comparison
Compare LENZ & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LENZ | AMRN |
|---|---|---|
| Founded | 2019 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.4M | 304.6M |
| IPO Year | 2021 | 1998 |
Fundamental Metrics
Financial Performance| Metric | LENZ | AMRN |
|---|---|---|
| Price | $9.97 | $14.79 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $45.60 | $12.00 |
| AVG Volume (30 Days) | ★ 1.1M | 42.6K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | N/A | ★ N/A |
| Revenue | $19,088,000.00 | ★ $181,104,000.00 |
| Revenue This Year | $51.35 | N/A |
| Revenue Next Year | $198.33 | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $8.25 | $9.44 |
| 52 Week High | $50.19 | $20.90 |
Technical Indicators
Market Signals| Indicator | LENZ | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 46.44 |
| Support Level | $8.99 | $13.65 |
| Resistance Level | $10.29 | $14.49 |
| Average True Range (ATR) | 0.68 | 0.56 |
| MACD | 0.25 | 0.02 |
| Stochastic Oscillator | 87.82 | 40.91 |
Price Performance
Historical ComparisonAbout LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.